Paid Clinical Trials for Glioblastoma

Showing 21 – 40 of 71 results

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

by CTG

in Brain Cancer, Glioblastoma, Brain Tumor, Brain Neoplasm, Brain Neoplasm, Malignant

Other

New York

Deadline:

12/01/2027

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

by CTG

in Glioblastoma

Other

Texas

Deadline:

01/31/2030

AB154 Combined With AB122 for Recurrent Glioblastoma

by CTG

in Glioblastoma

Other

California

Deadline:

12/31/2026

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

by CTG

in Glioblastoma

Other

New York

Deadline:

12/01/2031

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

by CTG

in Glioblastoma, Glioblastoma Multiforme of Brain, Recurrent Glioblastoma

Other

Pennsylvania

Deadline:

12/31/2026

Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors

by CTG

in Glioblastoma

Other

Michigan

Deadline:

06/01/2026

Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

by CTG

in Glioblastoma, Diffuse Glioma

Other

Arizona

Deadline:

09/07/2027

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

by CTG

in Glioblastoma

Other

Arizona

Deadline:

06/01/2026

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

by CTG

in Glioblastoma, WHO Grade III Glioma, WHO Grade II Glioma

Other

Texas

Deadline:

02/02/2027

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

by CTG

in Glioblastoma

Other

California

Deadline:

12/31/2026

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

by CTG

in Glioblastoma, Glioma, Brain Tumor

Other

Maryland

Deadline:

12/01/2027

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

by CTG

in Glioblastoma, Glioma, Metastatic Malignant Neoplasm in the Brain

Other

Minnesota

Deadline:

09/01/2027

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

by CTG

in Glioblastoma, Malignant Glioma, Gliosarcoma

Other

Maryland

Deadline:

12/31/2027

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

by CTG

in Glioblastoma

Other

Massachusetts

Deadline:

02/01/2027

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

by CTG

in Brain Cancer, Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme of Brain, Glioblastoma Multiforme, Adult

Other

Florida

Deadline:

12/01/2030

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

by CTG

in Glioblastoma

Other

North Carolina

Deadline:

12/10/2029

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

by CTG

in Glioblastoma

Other

Arizona

Deadline:

04/01/2029

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

by CTG

in Glioblastoma, Anaplastic Astrocytoma, Recurrent High Grade Glioma, Anaplastic Oligodendroglioma, Gliosarcoma

Other

Nebraska

Deadline:

03/01/2027

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

by CTG

in Glioblastoma, Glioblastoma Multiforme, Solid Tumor, Glioblastoma Multiforme of Brain

Other

Utah

Deadline:

04/30/2026

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

by CTG

in Glioblastoma

Other

Pennsylvania

Deadline:

07/01/2042

Load more All clinical trials loaded.

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

AB154 Combined With AB122 for Recurrent Glioblastoma

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors

Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Glioblastoma

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps